Matt Pilon

News Editor
(860) 236-9998 ext.143
Matt Pilon is news editor of the Hartford Business Journal. His core beats include health care and energy. Matt also oversees the HBJ's statewide energy quarterly, Connecticut Green Guide magazine. He has been with HBJ since 2013. Prior to that, he spent several years with HBJ's sister publication Worcester Business Journal. He has also previously reported for the Daily Hampshire Gazette in Massachusetts.

Bylines

Following setback, $200M Windsor Locks project begins local approval process

A Long Island developer whose ambitious $200 million proposed sports complex in Windsor Locks was sidelined last month amid concerns about his past...

Prudential, U.K. insurer ink $1.4B pension “de-risking” contract

Prudential's retirement division, which is headquartered in downtown Hartford, said it has signed a reinsurance deal under which it will assume...

Citing 'ridiculous' valuation, Icahn opposes Cigna-Express Scripts deal

Activist shareholder Carl Icahn is publicly opposing Cigna's proposed $67 billion acquisition of pharmacy benefits manager Express Scripts, arguing...

Target launching same-day delivery to two-thirds of CT households

Retail giant Target Corp. said it will start same-day delivery service for more than 2 million Connecticut households starting next week.

DEEP: Unhealthy air on CT’s coast

An unhealthy air quality warning has been issued for Connecticut’s southern coast, while the rest of the state will have air that’s...

Following shooting, Mutualink deepens Fla. customer base

Wallingford-based Mutualink said a Florida county school system has approved funding to use its school safety communications platform, designed to...

CT Green Bank takes novel approach to preserve clean-energy mission

In an unusual move for a state entity, the quasi-public Connecticut Green Bank has spun out a nonprofit to help it carry on several key...

Azitra wins $225K grant to study skin ailment

Farmington's Azitra says it won a $225,000 federal research grant to funds its pursuit of a treatment for a severe and extremely rare skin disease.

Copyright 2017 New England Business Media